person
Ketty P.
- Country
- Italy
- Department
- #40567:Dermatologia
Research Overview
assignment
57
Clinical Trials ·
- B7981040 - A PHASE 3 RANDOMIZED, DOUBLE-BLIND, 52-WEEK PLACEBOCONTROLLED, MULTI-CENTER STUDY INVESTIGATING THE EFFICACY, SAFETY, AND TOLERABILITY OF RITLECITINIB IN ADULT AND ADOLESCENT PARTICIPANTS WITH NONSEGMENTAL VITILIGO
- Efficacy and Safety of Zasocitinib in Pediatric Participants with Moderate-to-Severe Plaque Psoriasis: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Trial
- Phase 3 Extension Study of Long-Term Safety and Efficacy of Remibrutinib in Adults With Moderate to Severe Hidradenitis Suppurativa
location_city
2
Research Sites
Data & Insights
medical_services
Primary Speciality
Main therapeutic area
handshake
Return Partnerships
Recurring site collaborations
427
Sites with multiple studies
Has run more than one trial at 427 of 680 partner sites.
Specializations
Inflammatory Skin Conditions
Specialized in treating complex inflammatory dermatological conditions, with particular emphasis on atopic dermatitis and hidradenitis suppurativa.
- Moderate to Severe Atopic Dermatitis
- Hidradenitis Suppurativa
- Prurigo Nodularis
- Lichen Simplex Chronicus
Autoimmune Skin Disorders
Focused on investigating innovative treatments for autoimmune dermatological conditions, particularly targeting disorders affecting skin pigmentation and hair loss.
- Vitiligo
- Alopecia Areata
- Generalized Pustular Psoriasis
- Pyoderma Gangrenosum
Skin Cancer and Precancerous Conditions
Expert in treating various forms of skin cancer and related conditions, with specialized focus on basal cell carcinoma and associated syndromes.
- Basal Cell Carcinoma
- Cutaneous Squamous Cell Carcinoma
- Gorlin Syndrome
- Actinic Keratosis
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.